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Abstract
Background: Insulin-like growth factor-I (IGF-I) plays a crucial role in wound healing and tissue repair. We
tested the hypotheses that systemic administration of IGF-I, or growth hormone (GH), or both (GH+IGF-I) would
improve healing in collagenous connective tissue, such as ligament. These hypotheses were examined in rats that
were allowed unrestricted activity after injury and in animals that were subjected to hindlimb disuse. Male rats
were assigned to three groups: ambulatory sham-control, ambulatory-healing, and hindlimb unloaded-healing.
Ambulatory and hindlimb unloaded animals underwent surgical disruption of their knee medial collateral ligaments
(MCLs), while sham surgeries were performed on control animals. Healing animals subcutaneously received
systemic doses of either saline, GH, IGF-I, or GH+IGF-I. After 3 weeks, mechanical properties, cell and matrix
morphology, and biochemical composition were examined in control and healing ligaments.
Results: Tissues from ambulatory animals receiving only saline had significantly greater strength than tissue from
saline receiving hindlimb unloaded animals. Addition of IGF-I significantly improved maximum force and ultimate
stress in tissues from both ambulatory and hindlimb unloaded animals with significant increases in matrix
organization and type-I collagen expression. Addition of GH alone did not have a significant effect on either group,
while addition of GH+IGF-I significantly improved force, stress, and modulus values in MCLs from hindlimb
unloaded animals. Force, stress, and modulus values in tissues from hindlimb unloaded animals receiving IGF-I or
GH+IGF-I exceeded (or were equivalent to) values in tissues from ambulatory animals receiving only saline with
greatly improved structural organization and significantly increased type-I collagen expression. Furthermore,
levels of IGF-receptor were significantly increased in tissues from hindlimb unloaded animals treated with IGF-I.
Conclusion: These results support two of our hypotheses that systemic administration of IGF-I or GH+IGF-I
improve healing in collagenous tissue. Systemic administration of IGF-I improves healing in collagenous
extracellular matrices from loaded and unloaded tissues. Growth hormone alone did not result in any significant
improvement contrary to our hypothesis, while GH + IGF-I produced remarkable improvement in hindlimb
unloaded animals.
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Background
Insulin-like growth factor-I (IGF-I) plays a crucial role in
muscle regeneration, can reduce age-related loss of muscle
function, and cause muscle hypertrophy when over-
expressed [1-5]. These effects appear to be largely medi-
ated by promoting proliferation and differentiation of sat-
ellite cells [3] as well as promoting recruitment of
proliferating bone marrow stem cells to regions of muscle
tissue damage [6]. Furthermore IGF-I and growth hor-
mone (GH) are involved in a large variety of physiologic
functions and are reported to promote healing and repair
in bone [7,8], cartilage [9-11], gastric ulcers [12], muscle
[13,14], skin [15-17], and tendon [18,19]. This action is
largely mediated by the fact that GH and IGF-I directly
affect cells involved in the healing response [20-30], with
IGF-I having endocrine action, as well as local expression,
resulting in autocrine and/or paracrine signaling that
plays a role in proliferation, apoptosis, cellular differenti-
ation, and cell migration [31-36]. Insulin-like growth fac-
tor-I also stimulates fibroblast synthesis of extracellular
matrix (ECM) molecules such as proteoglycans and type I
collagen [18,30,37,38], and IGF-I mRNA and protein lev-
els are increased in healing ligaments [39] and tendons
[40], respectively. As such, IGF-I is of particular interest in
tissue regeneration due to its influence on cell behavior
and role in type I collagen expression.
Fibrous connective tissues, such as ligament and tendon,
are composed primarily of type I collagen with type III
collagen levels increased during healing [41]. During
development, collagen molecules organize into immature
collagen fibrils that fuse to form longer fibrils [42-45]. In
mature tendon and ligament these fibrils appear to be
continuous and transfer force directly through the matrix
[46]. In ligament, groups of fibrils form fibers and it is
these fiber bundles that form fascicles; the primary struc-
tural component of the tissue. Previous studies in healing
ligament have shown that disruption of the medial collat-
eral ligament (MCL) results in substantial reduction in
mechanical properties which does not return to normal
after long periods of healing [47]. Such tissue behavior is
likely associated with matrix flaws, reduced microstruc-
tural organization, and small diameter collagen fibrils in
the scar region of the ECM [48-50]. Additionally, during
normal ligament healing collagen fibrils from residual tis-
sue fuse with collagen fibrils formed in the scar region
[51]. However, in tissues which are exposed to a reduced
stress environment such as joint immobilization [52] or
hindlimb unloading [48] collagen fibers contain disconti-
nuities and voids [48] which likely account for the sub-
stantial decrease in tissue strength when compared to
ligaments experiencing physiologic stress during healing.
Since soft tissue injuries are common and do not heal
properly in a stress-reduced environment [48,52], such as
is present during prolonged bed rest or spaceflight, meth-
ods to further understand tissue healing and promote tis-
sue healing require study.
The purpose of this study is to test the hypotheses that sys-
temic administration of IGF-I, GH, or GH+IGF-I will
improve healing in a collagenous ECM. Furthermore,
since the addition of GH has been shown to up-regulate
IGF-I receptor [53], levels of IGF-I receptor in healing tis-
sues were examined in order to begin to elucidate the
molecular mechanism by which GH and/or IGF-I may be
acting to locally to stimulate tissue repair. Since IGF-I and
GH are feasible for clinical use, identifying benefits from
short-term systemic administration, such as improved
connective tissue healing, have great potential to improve
the human condition. The hypotheses are examined in
animals that are allowed normal ambulation after injury
and in animals that are subjected to disuse through hind-
limb unloading. The MCL was chosen as a model system
since this ligament, unlike tendons, has no muscular
attachment and therefore possible alterations in muscle
strength after IGF-I and/or GH treatment do not impose
substantial differential loads on the ligament during hind-
limb unloading. Furthermore, since MCLs have two
attachments/insertions into bone, and hindlimb unload-
ing/disuse is known to reduce the mechanical properties
of bone [48,54], failure location was recorded for all
mechanical testing. Results indicate improved mechanical
properties and collagen organization and composition of
the collagenous extracellular matrix following treatment
with IGF-I in both ambulatory and hindlimb unloaded
animals or IGF-I+GH in hindlimb unloaded animals.
Results
Initial body weights were not different between groups
and no wound infections or other apparent complications
associated with surgery were observed. All of the ambula-
tory animals returned to normal cage activity shortly after
surgery, and no treatment complications were observed in
the suspended animals. The hindlimb unloaded (HU)
animals were not able to gain weight as rapidly as the
ambulatory animals, thus significant differences (p <
0.0001) in body weight were observed between groups
after 10 days of healing. The GH, IGF-I, and GH+IGF-I
treatment increased body weight in HU animals (com-
pared to HU animals receiving only saline) but this differ-
ence was not statistically significant (p = 0.49, 0.49, and
0.26, respectively). No significant differences in body
weight were present between the ambulatory animals (all
p values > 0.38). At tissue harvest all healing ligaments
showed a bridging of the injury gap with translucent scar
tissue. In the ambulatory animals receiving GH, three ani-
mals had hematomas and tissue adhesions in the surgical
site. In all other animals no gross differences in the tissues
or the surgical wound site were observed.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
Page 3 of 17
(page number not for citation purposes)
The location of structural failure in each ligament was
examined, revealing that the majority of the femur-MCL-
tibia complexes failed in the MCL proper, not at the liga-
ment to bone insertion sites, nor by bone avulsion (Table
1). Sham control ligaments failed in the tibial third of the
ligament during 100% of the tests. For all other groups,
the primary location of failure was the scar region of the
ligament. The only exceptions to this were one failure in
the tibial third of the ligament in the Amb + IGF group,
one tibial avulsion in the HU + Sal group, and one tibial
avulsion in the HU + IGF group, indicating that a signifi-
cant portion of the failure locations was in the scar region
(all p values < 0.01). These results indicate the dominant
effects in the measured mechanical properties are due to
changes in ligamentous tissue and not in the insertions.
Substantial differences in tissue mechanical properties
were present between groups. Hindlimb unloading
adversely affected ligament healing while IGF-I or
GH+IGF-I had a substantial effect on ligament healing in
either ambulatory or hindlimb unloaded animals. Maxi-
mum force (Fig. 1) was significantly different between tis-
sues from Sham and both Amb + Sal and HU + Sal groups
(p = 0.0001 and p = 0.0001, respectively). Hindlimb
unloaded animals had significantly decreased maximum
force in the MCLs when compared to ambulatory healing
animals (Amb + Sal; p = 0.03). In ambulatory animals the
addition of IGF-I significantly improved maximum force
values by approximately 60% when compared to ambula-
tory healing animals that received saline (p = 0.0002).
Addition of IGF-I and GH+IGF-I in hindlimb unloaded
animals significantly increased maximum force values
(60% and 74%, respectively) when compared to HU + Sal
animals (p = 0.0074 and p = 0.0013, respectively). In fact,
addition of IGF-I or GH+IGF-I to hindlimb unloaded ani-
mals increased force to be comparable with Amb + Sal
animals. Growth hormone alone did not have a signifi-
cant effect within either the ambulatory or unloaded
groups. However, in the unloaded group, GH increased
maximum force and brought it closer to values in the Amb
+ Sal group, yet this increase was not statistically signifi-
cant (p = 0.16). Ultimate stress (Fig. 2) was significantly
decreased in tissues from both ambulatory healing and
hindlimb unloaded healing animals when compared to
sham control tissues (p = 0.0001 and p = 0.0001, respec-
tively). Ligaments from HU + Sal animals had ultimate
stress values that were significantly lower than saline
receiving ambulatory animals (p = 0.022). Addition of
only IGF-I to ambulatory animals significantly increased
ultimate stress when compared to Amb + Sal animals (p =
0.0077). Delivery of IGF-I and GH+IGF-I significantly
increased ultimate stress in tissues from the hindlimb
unloaded animals when compared to hindlimb unloaded
(plus saline) animals (p = 0.0236 and p = 0.0202, respec-
tively). In fact, ultimate stress values after the addition of
IGF-I or GH+IGF-I to hindlimb unloaded animals was
comparable to ultimate stress values in ambulatory ani-
mals receiving saline. In ambulatory animals, no statisti-
cally significant effect on ultimate stress values were seen
after GH or GH+IGF-I was administered. No significant
differences in strain at failure were present between
groups. Elastic modulus (Fig. 3) was statistically different
between IGF-I and saline treated ambulatory healing ani-
mals. Addition of IGF-I in ambulatory animals resulted in
an elastic modulus that had an ~49% greater mean value
(p = 0.049). In hindlimb unloaded animals the addition
of IGF-I or GH+IGF-I resulted in a significant increase in
modulus when compared to unloaded animals receiving
saline (p = 0.049 and p = 0.014, respectively). Growth
hormone alone had no significant effect on elastic modu-
lus in either group.
Representative H&E stained sections (Fig. 4) revealed
hypercellularity and extracellular matrix disorganization
in injured tissues from both ambulatory and suspended
animals. Ligaments from Sham animals demonstrated the
characteristic crimp pattern and aligned fibroblasts associ-
ated with normal ligament (Fig. 4). However, while Amb
+ Sal animals revealed normal scar morphology, tissues
from HU + Sal animals had pockets of cell clusters, cellu-
lar misalignment, and misaligned collagen bundles ori-
ented in separate directions creating discontinuities and
voids within the matrix confirming a previous report [48].
Furthermore, while matrices from animals treated with
GH had abnormal cell clusters and no gross improvement
in matrix organization in both ambulatory and unloaded
tissues, tissues from animals treated with IGF-I showed
substantially increased matrix density and collagen align-
ment (Fig. 4); a morphology also present in tissues from
HU + GH + IGF-I animals.
To further examine extracellular matrix organization in
histology sections, multiphoton laser scanning micros-
copy (MPLSM), which allows greatly enhanced imaging of
collagen structure, was employed (Fig. 5). Examination of
sham, ambulatory, and hindlimb unloaded tissues sup-
ports morphological information obtained with classical
histology (Fig. 4) and scanning electron microscopy [48],
with tissues from HU animals showing good fiber bundle
formation but fiber misalignment creating matrix discon-
tinuities and voids (Fig. 5). Confirming results obtained
from viewing H&E section with light microscopy, MPLSM
analysis showed improved matrix organization in tissues
from Amb + IGF-I, HU + IGF, and HU + GH + IGF-I ani-
mals (Fig. 5). In accordance with data showing increased
matrix deposition and organization (Figs. 4 and 5),
expression of type-I collagen was increased in tissues from
IGF-I treated ambulatory (p = 0.0018) and unloaded (p =
0.0006) animals and GH+IGF-I treated unloaded tissue (p
= 0.0005; Figs. 6A and 6B). Densitometry analysis furtherBMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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Table 1: Failure location of the bone-ligament-bone complex at 3 weeks post-injury.
Failure Location Scar Region Tibial Third of the Ligament Tibial Avulsion
Sham Control N/A 6 0
Amb + Saline 600
Amb + GH 600
Amb + IGF 510
Amb + GH + IGF 600
HU + Saline 501
HU+ GH 600
HU + IGF 501
HU+ GH + IGF 600
The strong majority (>96%) of tissues failed in the ligament and not by avulsion, indicating that the measured mechanical changes are due to changes 
in the ligament properties and not bone.
Maximum force values at 3 weeks (mean ± S.E.M.) Figure 1
Maximum force values at 3 weeks (mean ± S.E.M.). Maximum force was significantly decreased in tissues from hindlimb 
unloaded (HU) animals receiving saline when compared to tissues from Amb + Sal animals (p = 0.03). The addition of IGF-I sig-
nificantly improved maximum force in tissues from ambulatory healing animals when compared to tissues from ambulatory 
healing animals that received saline (p = 0.0002). Addition of IGF-I and GH+IGF-I in HU animals significantly increased maxi-
mum force values when compared to hindlimb unloaded animals receiving saline (p = 0.0074 and p = 0.0013, respectively). a 
significantly different from Sham group; b significantly different from Amb + Sal group; c significantly different from HU + Sal 
group.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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confirmed an increase in type-I collagen since the ratio of
type-I to type-III collagen was significantly increased in
tissues from ambulatory animals treated with IGF-I (p =
0.0129) and in unloaded tissues from GH+IGF-I treated
animals (p = 0.0131), with a trend of increased levels in
ambulatory GH+IGF and HU + IGF tissues (Fig. 7). Since
normal ligaments are primarily composed of type I colla-
gen and the scar region of normal healing ligaments con-
tain an increase in type III collagen [41] that is remodeled
to transition to more type I collagen rich region over the
healing period, changes in the type I to III ratio are a meas-
ure of healing and may indicate part of the structural
mechanism resulting in the observed differences in
mechanical properties following treatment.
Lastly, GH has been reported to increase levels of IGF
receptors [53]. Herein, ambulatory IGF-I and GH+IGF-I
treated animals showed a strong trend of increased IGF-I
receptor expression, although this trend was not signifi-
cant (Fig. 8). However, in hindlimb unloaded animals
treated with IGF-I or GH+IGF-I, IGF-I receptor expression
was significantly increased (Fig. 8). Hence, increased lev-
els of IGF-I receptor in healing tissues may be part of the
molecular mechanism by which systemic administration
Ultimate stress values at 3 weeks (mean ± S.E.M.) Figure 2
Ultimate stress values at 3 weeks (mean ± S.E.M.). Ultimate stress was significantly decreased in tissues from unloaded animals 
receiving saline when compared to tissues from Amb + Sal (p = 0.022). The additional of IGF-I significantly improved ultimate 
stress levels in tissues from ambulatory healing animals when compared to tissues from ambulatory healing animals which 
received saline (p = 0.0077). Addition of IGF-I and GH+IGF-I in hindlimb unloaded animals significantly increased ultimate 
stress values when compared to hindlimb unloaded animals receiving saline (p = 0.0236 and p = 0.0202, respectively). a signifi-
cantly different from Sham group; b significantly different from Amb + Sal group; c significantly different from HU + Sal group.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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of IGF-I and GH+IHG-I act to locally to stimulate tissue
repair.
Discussion
Previous work in our laboratory has shown that mechan-
ical properties and matrix organization of MCLs are sub-
stantially reduced after injury and that this impairment is
significantly compounded by stress reduction through
hindlimb unloading [48]. This result is confirmed by
examination of the mechanical properties in MCLs from
the saline receiving control groups in this study (Sham,
Amb + Sal, HU + Sal) which are not significantly different
from values obtained in our previous work in tissues from
sham, ambulatory healing, and hindlimb unloaded ani-
mals after three weeks of healing [48]. Furthermore, struc-
tural analysis of the matrix with MPLSM confirmed
previous morphological information obtained with elec-
tron microscopy [48], elucidating changes in the struc-
ture-function relationship, such as collagen fiber
misalignment and matrix voids, that help explain the
reduced mechanical properties associated with tissue
unloading (i.e. disuse).
Results of this study demonstrate a substantial increase in
healing with the systemic application of IGF-I in ambula-
tory and hindlimb unloaded animals and with GH + IGF-
I in hindlimb unloaded animals. Since the strong majority
of tissues failed in the ligament and not by avulsion, it is
clear that the mechanical properties of the ligament are
being evaluated and that systemic treatment with IGF-I or
GH+IGF-I improves the integrity of the collagenous
matrix. This finding is in contrast with results from heal-
ing tendons following local injections of IGF-I that
showed no significant improvement in the mechanical
Elastic modulus values at 3 weeks (mean ± S.E.M.) Figure 3
Elastic modulus values at 3 weeks (mean ± S.E.M.). The additional of IGF-I significantly improved elastic modulus levels in tis-
sues from ambulatory healing animals when compared to tissues from ambulatory healing animals which received saline (p = 
0.049). A significant increase in elastic modulus was present in tissues from hindlimb unloaded animals after the addition of IGF-
I or GH+IGF-I when compared to hindlimb unloaded animals receiving saline (p = 0.049 and p = 0.014, respectively). a signifi-
cantly different from Sham group; b significantly different from Amb + Sal group; c significantly different from HU + Sal group.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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Representative tissue sections taken from the midsubstance region of control normal tissue (Sham) and scar tissues (Saline, GH,  IGF-I, GH+IGF-I) Figure 4
Representative tissue sections taken from the midsubstance region of control normal tissue (Sham) and scar tissues (Saline, GH, 
IGF-I, GH+IGF-I). The longitudinal axis of the ligament is from the top left to bottom right of each image (200X). Tissues from 
sham control (Sham) animals have the characteristic crimp pattern and aligned fibroblasts associated with normal tissue. Exam-
ination of scar tissue from ambulatory healing animals (Amb + Sal) revealed typical scar morphology with matrix disorganization 
and hypercellularity. In contrast to ambulatory animals, hindlimb unloaded (HU + Sal) animals showed abnormal scar formation 
with pockets of cell clusters and misaligned collagen fibers creating defects and voids by not connecting. Examination of extra-
cellular matrices from GH treated animals revealed no improvement in matrix organization in tissues from ambulatory (Amb + 
GH) or hindlimb unloaded (HU + GH) animals. However, animals treated with IGF-I showed extensively increased matrix den-
sity and substantially improved matrix alignment in tissues from ambulatory (Amb + IGF) and hindlimb unloaded (HU + IGF) ani-
mals; indicating a considerable improvement in the matrix structure in animals treated with IGF-I. Animals that were treated 
with both GH and IGF-I showed similar improvement to that seen with IGF-I in unloaded tissues (HU + GH + IGF) but showed 
no improvement in ambulatory tissues (Amb + GH + IGF).BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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Multiphoton Laser Scanning Microscopy (MPLSM) was performed on hematoxylin and eosin sections in order to evaluate the  organization and structure of the collagen matrix in more detail then allowed by conventional brightfield light microscopy Figure 5
Multiphoton Laser Scanning Microscopy (MPLSM) was performed on hematoxylin and eosin sections in order to evaluate the 
organization and structure of the collagen matrix in more detail then allowed by conventional brightfield light microscopy. The 
longitudinal axis of the ligament is from the top to bottom of each image. Tissues from sham control animals have the character-
istic crimp pattern associated with normal tissue (Sham). Scar tissue from ambulatory healing animals (Amb + Sal) revealed typ-
ical scar morphology with matrix disorganization while hindlimb unloaded animals (HU + Sal) showed good fiber aggregation 
but possessed abnormal scar formation with misaligned collagen fibers not directed along the longitudinal axis of the tissue cre-
ating voids and defects by not connecting. Assessment of collagen matrices from GH treated animals revealed no improvement 
in matrix organization in tissues from ambulatory (Amb + GH) or hindlimb unloaded (HU + GH) animals. Examination of colla-
gen structure in animals treated with IGF-I supported data shown in Fig. 4 revealing greatly increased matrix density and con-
siderably improved matrix alignment in tissues from ambulatory (Amb + IGF) and hindlimb unloaded (HU + IGF) animals. 
Animals treated with GH+IGF showed no significant improvement in ambulatory tissues (Amb + GH + IGF) but unloaded tis-
sues (HU + GH + IGF) showed substantially increased matrix density and alignment.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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Significantly increased expression of type-I collagen in tissues from animals treated with IGF-I Figure 6
Significantly increased expression of type-I collagen in tissues from animals treated with IGF-I. (A: Left) Immunohistochemistry 
shows increased staining for type I collagen in ambulatory tissues when compared to Sham, while hindlimb unloaded tissues 
show no increase. In tissues from ambulatory and hindlimb unloaded animals treated with IGF-I type I collagen staining is 
increased. GH+IGF-I also results in increased collagen expression in unloaded tissues. (A: Right) Thresholded images utilized for 
quantitative analysis of expression. (B) Quantitative analysis of type I collagen expression. Ambulatory healing (Amb + Sal) tis-
sue had significantly more collagen expression when compared to sham tissues (** p = 0.0002) while unloaded tissues did not. 
GH showed no significant increase between saline treated animals. Ambulatory IGF-I treated animals had significantly (*) 
increased type-I collagen protein expression (p = 0.0018) when compared to ambulatory animals treated with saline. Tissues 
from GH+IGF treated ambulatory and hindlimb unloaded animals had significantly (# p = 0.0006 and p = 0.0005, respectively) 
increased collagen expression when compared to hindlimb unloaded tissues given saline.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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properties of treated tendons [18], indicating that local
and systemic administration of IGF-I may act through dif-
ferent mechanisms. Furthermore, it is interesting that IGF-
I alone positively influenced healing in tissues from both
ambulatory and hindlimb unloaded animals, while com-
bined GH and IGF-I only had a positive affect on tissues
from HU animals. Since IGF-I increased tissue strength
measures by ~60% in both ambulatory and hindlimb
unloaded animals, it appears that IGF-I improves healing
regardless of mechanical loading and that the affects of
mechanical loading and IGF-I may be additive. The
GH+IGF-I associated improvement observed only in
hindlimb unloaded animals is more difficult to interpret.
Nonetheless, this difference between ambulatory and HU
animals after GH+IGF-I treatment may result from
changes in the endocrine system due to unloading [55-57]
Densitometry analysis of type I and III collagen expression Figure 7
Densitometry analysis of type I and III collagen expression. Quantification of Western blots for type I and III collagen indicated 
that the ratio of type I to type III collagen was significantly increased in tissues from ambulatory animals treated with IGF-I (* p 
= 0.0129) and in unloaded tissues from GH+IGF-I treated animals (p = 0.0131), when compared to saline treated ambulatory 
and hindlimb unloaded tissues. Note: the values for each group were normalized to the Sham group (ratio set to one) to allow 
comparison of data across multiple Western blot experiments.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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or an inhibitory role of exogenously elevated GH on IGF-
I function. Decreased levels of growth hormone, and
changes in other endocrine factors, with unloading have
been reported [55-60], and the addition of GH in
unloaded rats may be simply re-establishing basal GH
behavior in unloaded animals allowing the influence of
increased IGF-I to proceed. In contrast, elevated levels of
GH in ambulatory animals inhibit the positive affect of
IGF-I, indicating that in fact elevated GH in ambulatory
animals may not be permissive to elevated IGF-I function,
but that improved healing from IGF-I addition is not
dependent on exogenously elevated GH levels. Interest-
ingly, addition of GH alone showed a trend of decreasing
the mechanical properties of healing ligaments and
hematomas in the healing site, further supporting the
concept of a negative role for GH in ligament healing,
even though combined supplementation of GH+IGF-I has
been reported to increase serum IGF-I levels more than
adding IGF-I alone [61,62]. Hence, the behavior reported
herein is a complex phenomena superimposing the influ-
ence of mechanotransduction during tissue loading, local
growth factor signaling, and endocrine hormone levels,
yet implies a positive role for IGF-I and a negative role for
GH in connective tissue healing through mechanisms that
are, to date, not well understood.
Densitometry analysis of IGF-I receptor expression Figure 8
Densitometry analysis of IGF-I receptor expression. Ambulatory IGF-I and GH+IGF-I treated animals showed a strong trend of 
increased IGF-I receptor expression, however, this trend was not significant. In hindlimb unloaded animals treated with IGF-I 
or GH+IGF-I, IGF-I receptor expression was significantly increased compared to saline treated hindlimb unloaded animals, indi-
cating a possible role for localized increases in IGF-I receptor to play a role in mediating improvements seen in the structure 
and function of treated ligaments.BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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Connective tissue atrophy and diminished levels of heal-
ing after disuse (e.g. spaceflight, hindlimb unloading,
immobilization, etc.) is associated with reduced physical
stimuli, however local growth factor signaling, and endo-
crine factors also play an important role. For instance, it is
well established that microgravity or simulated micro-
gravity disrupts pituitary GH function [58-60] and alters
IGF-I expression and plasma concentration [60,63]. Inter-
estingly, in this study the addition of GH alone, which can
bind to cells via specific surface receptors activating
numerous signaling pathways that direct changes in gene
expression [64-67], did not offer any significant increase
in mechanical properties. In contrast, the addition of IGF-
I significantly improved the mechanical properties of tis-
sues in treated animals, likely through structural improve-
ments in the extracellular matrix as seen in Figures 4 and
5. In ambulatory animals treated with IGF-I and unloaded
animals treated with IGF-I or GH+IGF-I, MCL matrix
organization was greatly improved. This may be due to
increased type-I collagen expression resulting in increased
the matrix density, and altered cell behavior resulting in a
more organized collagen matrix. Given the clear increases
in matrix alignment, it appears probable that either colla-
gen organization is initially improved during post-fibrill-
ogenesis deposition or better organized during continued
matrix remodeling, or both. Since collagen alignment is
achieved before substantial tissue loading during fetal
development [46,68], which is not reproduced during tis-
sue repair in unloaded mature tissue [48], and it appears
that matrix repair in adult tissue may be an imperfect
reversion to processes seen in fetal development [46],
addition of IGF-I may be stimulating signaling pathways
similar to those seen during development. Moreover, one
possible link in the molecular mechanism playing a role
in increased matrix organization and collagen expression
may be signals associated with IGF-I receptor signaling as
indicated by increased IGFR levels in treated animals.
However, IGFR activation was not examined in this study
and multiple pathways associated with IGFR and matrix
adhesion signaling (i.e. integrin signaling) are likely act-
ing in concert to produce the profound improvements
seen after IGF-I treatment. Hence, it is clear from these
data that further work studying the systemic effects IGF-I
need to be performed in order to better understand the
mechanism of IGF-I administration on local tissue behav-
ior.
It is known that soft tissue injuries do not fully recover
even after long periods of healing [47] and stress reduc-
tion has a negative effect on healing in collagenous tissue,
[48,52] which does not return to normal after re-estab-
lishing physiologic stress (i.e. remobilization) [69]. This
pattern of healing is problematic since the injured joint
often need immobilization, the growing aged population
often experiences decreased activity levels or prolonged
bed rest, and since prolonged space flight is becoming
more feasible. Therefore, methods to improve tissue heal-
ing and counteract this negative decline during injury
and/or disuse are increasing in need. The reported appli-
cation of IGF-I clearly has a positive effect on tissue repair
from a mechanical (functional) viewpoint, and therefore
shows promise to improving normal tissue healing and to
improving healing under normal or disuse conditions. Of
particular note is the increase in force, stress, and elastic
modulus in tissues from unloaded animals with IGF-I or
GH+IGF-I, which become comparable to or surpass levels
in ambulatory (Amb + Sal) animals. This improvement in
tissue properties compares well with other methods to
improve tissue repair, but may be more clinically feasible.
For instance, application of PDGF-BB has also shown
promising improvements in fibrous connective tissue
healing. In two studies allowing unrestricted cage move-
ment, Batten and co-workers [70] reported increases in
maximal force up to 90% of controls, and Hildebrand and
co-workers [71] reported increases in force of ~50% after
PDGF-BB was administered locally immediately follow-
ing injury. However, administering PDGF-BB 48 hrs post-
injury resulted in decreased force values [70], while
administering IGF-I post-injury herein improved tissue
healing. Therefore, the results presented in this paper
showing an increase in maximal force of ~60% in ambu-
latory animals after 3 weeks of systemic IGF-I compares
favorably to the levels of improvement previously
reported in the literature but treatment can begin post-
injury. Yet, although short term systemic application of
IGF-I or GH+IGF-I provide compelling evidence for
improved healing in a collagenous matrix, potential side
effects of altering GH and IGF-I levels for long periods of
time have not yet been fully explored in conjunction with
these data and therefore further study is required before
long term use is warranted in humans.
Conclusion
In conclusion, results support our hypothesis that sys-
temic administration of IGF-I improves healing in colla-
genous extracellular matrices. Growth hormone alone did
not result in any significant improvement contrary to our
hypothesis, while GH + IGF-I produced remarkable
improvement in hindlimb unloaded animals. Interest-
ingly, addition of IGF-I or GH + IGF-I in HU animals
resulted in recovery of strength measures to a level equal
to ambulatory controls, indicating that in fact IGF-I may
be a plausible therapy for overcoming reduced tissue heal-
ing due to disuse from bed rest, immobilization, or micro-
gravity. Additionally, although supplementation with
IGF-I in ambulatory animals did not result in full recovery
of the mechanical properties at 3 weeks, treatment
resulted in an ~60% increase in tissue strength demon-
strating the potential for IGF-I to improve tissue healing.
These changes in tissue healing with tissue loading or IGF-BMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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I supplementation raise important questions regarding
the essential role of mechanical stress for collagen matrix
organization in connective tissues and the mechanisms by
which systemic IGF-I or GH+IGF-I lead to improved tissue
healing.
Methods
Animal model and study design
This study was approved by the institutional animal use
and care committee and meets N.I.H. guidelines for ani-
mal welfare. Seventy-two male Sprague-Dawley rats (248
± 6 grams) were used as an animal model. These animals
were randomly divided into nine groups each containing
eight rats: 1) sham control surgery - ambulatory + saline
(Sham), 2) healing - ambulatory + saline (Amb + Sal), 3)
healing - hindlimb unloaded + saline (HU + Sal), 4) heal-
ing - ambulatory + GH (Amb + GH), 5) healing - hind-
limb unloaded + GH (HU + GH), 6) healing - Ambulatory
+ IGF-I (Amb + IGF), 7) healing - hindlimb unloaded +
IGF-I (HU + IGF), 8) healing - ambulatory + GH + IGF-I
(Amb + GH + IGF), 9) healing - hindlimb unloaded + GH
+ IGF-I (HU + GH + IGF). Each rat in the ambulatory heal-
ing and hindlimb suspension (unloaded) groups under-
went aseptic surgery to disrupt both knee MCLs. Rats were
anesthetized with an isofluorane anesthetic administered
by facemask using a non-rebreathing delivery system. The
incision area was clipped and prepared for surgery. A skin
incision approximately 8 mm long was made on the
medial side of the stifle and fascia was incised to expose
the MCL. The MCL was exposed and transected at the joint
line, after which the muscles and skin were closed with
suture. Sham control animals were subjected to identical
surgical procedures without MCL disruption. All animals
were given an analgesic (Tylenol®/codeine) in their water
for 72 hours post-surgery. Animals in the sham control
and ambulatory healing groups were allowed unrestricted
cage movement. Hindlimb unloaded healing rats were
subjected to hindlimb unloading (24 hours after surgery),
which induced substantial stress reduction by eliminating
ground reaction forces, using the noninvasive tail suspen-
sion protocol of the NASA-Ames center [72]. Only the
hindlimbs were suspended (unloaded) and the animals
were allowed to move freely within the cages using the
forelimbs while being restricted from kicking the sides of
the cages. For GH and IGF-I delivery, recombinant human
GH or IGF-I (Genentech, South San Francisco, CA) was
dissolved in sterile saline at a concentration of 0.25 mg/
mL. Rats received two 0.5 mL injections daily (0830 and
1530 hours) of GH, IGF-I, or GH+IGF-I subcutaneously in
the nape of the neck. The dosage of GH and IGF-I were
based upon previous studies in rats [73-75] based on ini-
tial body weight and was not adjusted during the course
of the study. Combined GH and IGF-I were administered
since previous reports have shown that increased levels of
serum IGF-I and IGF-I binding proteins are obtained after
co-injection of GH and IGF-I when compared to either
GH or IGF-I alone [61,62]. All animals were housed at
24°C under a 12 hr light and 12 hr dark cycle, fed Purina
rat chow, and watered ad libitum. Rats were checked twice
daily for overall health, skin incision healing, food and
water consumption, and the condition of their tails (the
harness should prevent slippage without restricting circu-
lation). After 3 weeks the animals were euthanized.
Immediately after death, animal hindlimbs were flash fro-
zen and stored at -80°C until testing. Of the sixteen liga-
ments per group, six ligaments were used for mechanical
testing, six for histology and immunohistochemistry, and
four for Western blotting.
Biomechanical testing
On the day of testing, hindlimbs were thawed at room
temperature from -80°C. It has been shown that postmor-
tem storage by freezing does not change the biomechani-
cal properties of ligament [76]. Tissue harvest and testing
were performed using methods similar to those previ-
ously described [48,77]. Extraneous tissue was carefully
dissected away to expose each MCL and the femur-MCL-
tibia complex was removed. Ligaments were kept moist in
PBS at 25°C to prevent dehydration (pH = 7.4), and cross
sectional area measured optically. While remaining
hydrated the femur-MCL-tibia complex was placed into a
custom designed tissue bath system with special structures
to hold the femoral and tibial bone sections of the sample
along the longitudinal axis of the MCL where all fibers
appear to load simultaneously (~70° flexion). For tissue
strain measurement, optical markers (impregnated car-
bon grease) were placed onto the ligament tissue near the
insertion sites and the tissue bath containing the MCL
samples were inserted into our custom testing machine. A
small preload of 0.1 N was applied in order to obtain a
uniform start (zero) point. The ligaments were precondi-
tioned (~1% strain for 10 cycles) to allow the tissues to
settle into the grips of the testing bath and then they were
pulled to failure in displacement control at 10 %/s. Tissue
deformation was examined and recorded until post-fail-
ure. Digital images of each test were analyzed to assess the
structural failure location. For the case of a potential tibial
avulsion the distal end of the ruptured tissue was exam-
ined for bone.
Tissue displacement was obtained using video dimen-
sional analysis (resolution = 10 μm). The change in dis-
tance between optical markers was calculated by
analyzing digital frames from the test with N.I.H. Image
using a custom macro to calculate the change in x-y coor-
dinate center (centroid coordinates) of each marker. Force
(resolution 0.005 N) was obtained, displayed on the
video screen and synchronized with displacement. From
displacement data, engineering strain was calculatedBMC Physiology 2007, 7:2 http://www.biomedcentral.com/1472-6793/7/2
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where L0 is the initial length of the tissue at preload (0.1
N) and L is the current distance between strain markers:
The stretch ratio is represented by λ and is the current
length divided by the original length. Lagrangian stress
was calculated as the current force (F) divided by the ini-
tial undeformed area (A0):
Stress versus stretch-ratio curves were created and fit with
the microstructural model presented by Hurschler and co-
workers [78] to obtain the elastic modulus. Biomechani-
cal parameters for comparison are ultimate force, ultimate
stress, strain at failure, and elastic modulus (determined
from the microstructural model).
Histology and immunohistochemistry
Immediately following tissue harvest, samples for histol-
ogy were fixed in 10% formalin. After standard histology
procedures, sections underwent hematoxylin and eosin
(H&E) staining. Slides were coverslipped and viewed with
light microscopy. For immunohistochemistry, fixed liga-
ments were flash frozen in Optimal Cutting Temperature
Media (OCT) at -70°C. Cryosections (6 μm) of each MCL
were mounted onto lysine coated slides for staining.
Mounted specimens were washed in a solution of PBS and
0.1% Tween-20 (PBST) between all incubation steps.
Endogenous peroxidase activity was blocked by incubat-
ing slides in 3% hydrogen peroxide for 10 minutes, fol-
lowed by blocking with 5% goat serum for 30 minutes at
room temperature in a moist chamber. Tissue sections
were then incubated for one hour at room temperature in
a 1:1 dilution of SP1.D8 (University of Iowa Develop-
mental Studies Hybridoma Bank), a primary antibody
against the amino-terminal of type I procollagen. Sections
were then incubated in rat adsorbed secondary antibody
(Innovex Biosciences, Parsippany, New Jersey) for 20
minutes at room temperature, followed by incubation in
horseradish peroxidase (HRP) labeled strepavidin
(Innovex Biosciences, Parsippany, New Jersey) for 20
minutes at room temperature. Slides were stained with
DAB (3,3'-diaminobenzidine; Innovex Biosciences, Par-
sippany, New Jersey) for 5 minutes at room temperature,
and then washed in distilled water (twice) for 5 minutes.
No counterstaining was performed and no primary anti-
body and a species appropriate IgG antibody served as
negative controls. All slides were dehydrated in graded
ethanol solutions, and then cleared in xylenes prior to
cover-slipping. Light microscopy was used to examine
each specimen and digital images of each MCL specimen
were taken at 100× magnification. The area of staining
was measured using ImageJ software after establishing a
constant threshold across images.
Multiphoton laser scanning microscopy
Multiphoton Laser Scanning Microscopy (MPLSM) was
performed on hematoxylin and eosin stained slides using
an optical workstation [79,80] to better examine collagen
organization in tissue sections. Since, MPLSM of formalin
fixed paraffin embedded sections produces images of col-
lagen structure and organization that far exceed the detail
provided with standard histology under brightfield illu-
mination, MPLSM was employed to detect potential dif-
ferences in collagen matrix organization that have been
previously reported in healing ligaments from ambula-
tory and hindlimb unloaded animals using scanning elec-
tron microscopy [48]. The excitation source was a
Ti:sapphire laser (Spectra-Physics-Millennium/Tsunami,
Mountain View, CA) producing around 100fs pulse
widths and tuned to 890 nm. The beam was focused onto
the sample with a Nikon 40X Plan Fluor oil-immersion
lens (N.A. = 1.4).
Western blot analysis
Ligaments were finely minced and boiled in 3X Laemmli
buffer for 10 minutes. Following centrifugation to remove
tissue debri, protein was separated by SDS-PAGE on 7.5%
gel, and electro-transferred to PVDF membrane (Milli-
pore, Billerica, MA). Membranes were blocked with TBST
(10 mM Tris, 150 mM NaCL, 0.3% Tween-20) plus 5%
Blotto (Santa Cruz Biotechnology, Santa Cruz, CA), fol-
lowed by incubation with either rabbit anti-collagen type-
I (Biotrend, Germany) or mouse anti-collagen type-III
(Abcam; FH-7A) for 30 minutes at 37°C or anti-IGF-I
receptor antibody (Cell Signaling Technology, Danvers,
MA) overnight at 4°C. The membrane was then incubated
in secondary HRP-conjugated donkey anti-rabbit or anti-
mouse antibody (Jackson ImmunoResearch Lab; 0.8 μg/
mL) and visualized using the ECL Plus detection reagent
(Amersham, Piscataway, NJ). For analysis of the ratio of
collagen I to III the membranes were probed for type III
collagen then stripped and re-developed to confirm the
absence of residual signal, and then reprobed for type I
collagen. IGF-I receptor levels were normalized to levels of
GAPDH (anti-GAPDH; Santa Cruz Biotechnology, Santa
Cruz, CA). Following automated development of a
number of exposures to confirm linearity, densitometry
analysis was performed with ImageJ software. The values
for each group were normalized to the Sham group to
allow comparison of data across multiple Western blot
experiments. Specificity of the collagen antibodies was
confirmed by blotting purified type I and III collagen (BD
Biosciences) and a panel tissues known to be composed of
types I and III collagen. Cross-reactivity of the antibodies
for other collagens was negligible (data not shown). The
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anti-collagen type I antibody did not cross-react with type
III collagen consistent with the manufacturers report that
the antibody has minimal cross reactivity to types II, III,
IV, V, and VI collagen. The anti-collagen type III antibody
did not substantially cross-react with type I collagen con-
sistent with the manufacturers data indicating that the
antibody does recognize collagen types I, II, IV, V, VI and
X.
Statistical analysis
Due to the non-factorial nature of our experimental
design, statistical analysis was performed using a one-way
analysis of variance (ANOVA) followed by pair wise com-
parisons. The level of significance was set to 0.05 and
analysis was performed with SAS PROC MIXED (SAS
Institute, Inc., Cary, NC). Fisher's protected least signifi-
cant difference test was used for post-hoc multicompari-
sons. For analyzing failure location data, the non-
parametric Kruskal-Wallis test was performed.
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